Clinical Trial Update: Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study [Phase 2]

View source ↗

Summary

Phase II, single-arm trial evaluating SOX regimen plus camrelizumab as neoadjuvant therapy for locally advanced gastric cancer; study status ACTIVE_NOT_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Neoplasms

Drugs mentioned

• SOX regimen + camrelizumab

Snippet

Sponsor: The Second Affiliated Hospital of Fujian Medical University | Conditions: Stomach Neoplasms, Digestive System Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING